Ihr Broker

  • DAX 0,70
  • EUR/USD 0,50
  • GOLD 0,30

Nur Spreads

Keine Kommission

Jetzt registrieren

CFDs sind komplexe Instrumente und umfassen aufgrund der Hebelfinanzierung ein hohes Risiko, schnell Geld zu verlieren.

Carl Zeiss Meditec AG, DE0005313704

Carl Zeiss Meditec AG, DE0005313704

02.10.2019 - 09:16:44

Carl Zeiss Meditec AG achieves significant growth in revenue and profit in fiscal year 2018/19

Carl Zeiss Meditec AG achieves significant growth in revenue and profit in fiscal year 2018/19 Jena, October 2, 2019 Carl Zeiss Meditec AG (ISIN: DE0005313704) has achieved revenue of approximately EUR 1,459 million in fiscal year 2018/19 (PY: EUR 1,280.9 million), based on preliminary data, and has thereby significantly exceeded the previous forecast of EUR 1,350 to EUR 1,420 million. This corresponds to revenue growth of approximately 13.9% vs. the previous year's value. After adjustment for currency effects[1], growth amounts to around 11.9 %. From today's point of view, the company expects a strong increase in operating earnings[2] (EBIT) and anticipates to significantly exceed the previous forecast of an EBIT margin[3] between 15.0% to 17.5% (PY: 15.4%) as well as current market expectations estimated at around 18.5%. Full results for business year 2018/19 will be provided on Dec 6, 2019. As already reported after nine months 2018/19, management expects no further sustainable increase in EBIT margin in fiscal year 2019/20, partly due to planned strategic investments in research and development.    

Contact for investors and press Sebastian Frericks Director Investor Relations Carl Zeiss Meditec AG Tel.: +49 3641 220-116 E-Mail: investors.meditec@zeiss.com

[1] Currency-adjusted sales growth is determined by weighing sales in the comparative period with current instead of actual historical exchange rates.[2] Earnings before interest and taxes (also operating profit, EBIT) refers to a key earnings figure within the Carl Zeiss Meditec Group and is calculated in accordance with IFRS standards (see Annual Report 2017/18, p. 76 for reconciliation).[3] Calculation: EBIT margin = EBIT / revenue (in %) (see Annual Report 2017/18, p. 76).

02-Oct-2019 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language: English Company: Carl Zeiss Meditec AG Göschwitzer Str. 51-52 07745 Jena

Germany Phone: +49 (0)3641 220-0 Fax: +49 (0)3641 220-112 E-mail: investors.meditec@zeiss.com Internet: www.zeiss.de/meditec-ag/ir ISIN: DE0005313704 WKN: 531370 Indices: MDAX, TecDAX Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange EQS News ID: 884075   End of Announcement DGAP News Service

884075  02-Oct-2019 CET/CEST

@ dgap.de